Machine Learning

A French biotech is advancing a novel class of drugs that don't just fight cravings but may reverse the deep-seated brain changes caused by addiction.

The philanthropic arm of corrections tech firm ViaPath offers new funding to nonprofits aiding youth, veterans, and justice-impacted individuals.

Acumatica's 2026 Summit showcases practical AI tools, strategic acquisitions, and a major push to embed financial automation directly into its ERP.

With new President and CTO appointments, Hermeus signals a major shift from R&D to full-scale production of its high-Mach aircraft for defense.

A new report details a dramatic rise in ransomware and supply chain attacks, turning digital threats into life-or-death crises for the global health sector.

PPB Capital Partners partners with Delio to enhance its PIX platform, aiming to give advisors a competitive edge in the crowded private markets space.

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

The strategic acquisition unites AI design with sequencing analytics, creating an end-to-end platform poised to accelerate RNA therapeutic development.

As AI and algorithms reshape our world, the National Cybersecurity Alliance offers expert guidance to help you protect your personal data and digital footprint.

A new AI platform from Eurofins CDMO Alphora predicts optimal drug forms, promising to cut costs and accelerate the path from lab to patient.

A new alliance aims to move beyond simple AI content creation, using autonomous AI agents to orchestrate entire marketing campaigns from start to finish.

ePIC's new 1.5% firmware fee for its UMC OS democratizes elite mining tools, forcing a rethink of profitability and challenging hardware reliance.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Avant Technologies is evaluating a therapy to protect insulin cells from immune attack, a breakthrough that could end the need for harsh drugs.

A new survey shows nearly half of Americans trust influencers and AI for diet advice, sparking a major campaign to reclaim trust in science-based care.

As AI adoption soars, why is worker productivity lagging? Degreed's LENS 2026 conference gathers experts to solve the human-machine collaboration puzzle.

ControlUp's new Live Remote Management streams live data and enables silent fixes, promising to end user disruption and make IT support invisible.

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

MACOM promotes key executives, signaling a dual focus on strategic acquisitions and pioneering Gallium Nitride semiconductor technology.

New data reveals a crisis of distraction. With meetings doubling and app overload, workers are losing the ability to concentrate. Is your company to blame?